by Waylon Wright | Dec 13, 2016
Stem cell research and therapy understandably accounts for much excitement and caution within the life science community and general population. The potential applications of stem cell therapy, from regenerating organs and limbs to fighting cancer, seem endless. The...
by Waylon Wright | Dec 10, 2016
America prides itself as a leader in technological innovation and medical research. Home to some of the largest and well respected cancer centers in the world, the U.S. has stood as the epicenter for cancer research for several decades. If the U.S. wishes to retain...
by Waylon Wright | Dec 2, 2016
The European Medicines Agency (EMA) released a report on Tuesday that analyzed over 100 applications submitted for medicines in the fields of psychiatry or neurology between 1995 and 2014. In the report, EMA concludes that various challenges can arise in the...
by Waylon Wright | Dec 1, 2016
The 2st Century Cures Act, a nearly 1,000 page bill that details changes for the Food and Drug Administration (FDA) and National Institute of Health (NIH), passed by a vote of 392-26 today in in the House of Representatives. A Senate vote could come as soon as next...
by Waylon Wright | Dec 1, 2016
Pearl Pathways is pleased to announce the hiring of Shawn Knopp, PhD as an Advisor serving medical device and biopharmaceutical life science companies. Knopp brings to Pearl Pathways over 15 years of experience in multi-disciplinary life science roles including...
